If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
49.15    1.65 (3.47%)
Bid:
48.75
Ask:
49.75
Spread: 1.00 (2.051%)
Market Cap: £195.67m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Disposal

13 Oct 2022 07:00

RNS Number : 7074C
CLS Holdings PLC
13 October 2022
 

 

 

PRESS RELEASE

 

 

Release date: 13 October 2022 

Embargoed until: 07:00 am 

 

 

CLS Holdings plc ("CLS" or the "Group")

CLS announces the sale of Sentinel House for £7.0 million, 4.5% above valuation

 

CLS announces that it has simultaneously exchanged and completed on the sale of Sentinel House in Coulsdon, Greater London, for £7.0 million excluding costs.

 

Sentinel House was acquired by CLS in 2012 and consists of 3,211 sqm (36,711 sq. ft) of office space over 3 floors with ancillary car parking. Throughout our ownership the asset has been let on an FRI basis to IHS Global Limited which will expire at the end of 2022.

 

The sale, at a price 4.5% above the 30 June 2022 valuation, allows CLS to crystallise the returns on the asset while releasing capital to strengthen its liquid resources.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"The sale of Sentinel House is in line with CLS' asset management strategy and secures a significant return on the asset, capturing value for investors while increasing financial flexibility for the Group. The Group remains convinced of the attractions of well-located, high-quality offices in non-prime locations whilst continually assessing whether to hold or sell properties in-line with CLS' business model."

 

 

-ends-

 

For further information, please contact:

 

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Limited

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg Matthew ArmittRichard Bootle+44 (0)20 3207 7800

Edelman Smithfield (Financial PR)

Alex Simmons 

Hastings Tarrant

+44 (0)20 3047 2546

Registered in England No. 2714781. Registered Office as above.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFLFVRIFLFLIF
Date   Source Headline
13th May 20206:02 pmRNSDirector/PDMR Shareholding
13th May 20206:00 pmRNSDirector/PDMR Shareholding
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio
11th Dec 20195:16 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Statement
20th Nov 20197:00 amRNSAppointment of independent Non-Executive Director
13th Nov 20197:00 amRNSAcquisition
8th Nov 20194:07 pmRNSDirector/PDMR Shareholding
17th Oct 20194:53 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSAcquisition
11th Oct 20195:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSAcquisition
6th Sep 20195:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSShareholding in Catena AB
2nd Sep 20194:31 pmRNSShareholding in Catena AB
14th Aug 20194:05 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 20199:09 amRNSDirector/PDMR Shareholding
5th Aug 20195:06 pmRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.